Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow mononuclear cell injection for no-option ischemic heart failure
2009-016364-36Phase 3Completed
- Start
- Dec 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial in Ischemic congestive heart failure (ICM-HF) and heart failure (HF) comparing Autologous bone marrow-derived mononuclear cells with Placebo (2 arms). Primary endpoint: Left ventricular global ejection fraction. Started Dec 2009; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Ischemic congestive heart failure (ICM-HF)heart failure (HF)
Beyond the preview
Go deeper on 2009-016364-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016364-36.